drugset / Trial / NCT03968562

Assessment of Suppression of Cutaneous Allergic Responses and Pruritus by Topical Doxycycline

NCT03968562

RandomizedSingle-groupSingle-blindTreatment

Summary

Investigators will study the effects of topical doxycycline on cutaneous allergic early and late phase responses by determining allergen skin responses in each subject after a single application to allergen induced allergic swelling of 2% doxycycline in emollient.

Timeline

Start
2019-05-15
Primary completion
2022-05-14
Completion
2022-05-14

Drugs

EvaluationDrugModalityDoseRoute
Comparator Doxycycline Small molecule 2 % Topical

Indications